1. Home
  2. BEAM vs FCPT Comparison

BEAM vs FCPT Comparison

Compare BEAM & FCPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$29.02

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Four Corners Property Trust Inc.

FCPT

Four Corners Property Trust Inc.

HOLD

Current Price

$25.19

Market Cap

2.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEAM
FCPT
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BEAM
FCPT
Price
$29.02
$25.19
Analyst Decision
Buy
Buy
Analyst Count
12
7
Target Price
$50.75
$28.00
AVG Volume (30 Days)
1.8M
762.8K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
5.79%
EPS Growth
82.31
1.87
EPS
N/A
0.28
Revenue
$24,000.00
$294,132,000.00
Revenue This Year
N/A
$6.66
Revenue Next Year
$33.77
$8.28
P/E Ratio
N/A
$88.68
Revenue Growth
33.33
9.72
52 Week Low
$15.60
$22.78
52 Week High
$36.44
$27.85

Technical Indicators

Market Signals
Indicator
BEAM
FCPT
Relative Strength Index (RSI) 47.10 54.42
Support Level $26.96 $24.96
Resistance Level $29.06 $25.79
Average True Range (ATR) 2.12 0.51
MACD -0.21 0.06
Stochastic Oscillator 11.71 79.50

Price Performance

Historical Comparison
BEAM
FCPT

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About FCPT Four Corners Property Trust Inc.

Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.

Share on Social Networks: